Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
16,255,471
-
Share change
-
+16,255,471
-
Total reported value
-
$250,516,107
-
Price per share
-
$15.44
-
Number of holders
-
55
-
Value change
-
+$250,516,106
-
Number of buys
-
55
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q1 2018
As of 31 Mar 2018,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,255,471 shares.
The largest 10 holders included
Alphabet Inc., EcoR1 Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, Partner Fund Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Foresite Capital Management IV, LLC, Board of Trustees of The Leland Stanford Junior University, JANUS HENDERSON GROUP PLC, and Hillhouse Capital Management, Ltd..
This page lists
55
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.